HYDERABAD, India, Feb. 10, 2012 /- Neuland Laboratories Ltd., (NSE: NEULANDLAB; BOM: 524558) a pharmaceutical manufacturer providing active pharmaceutical ingredients (APIs), complex intermediates and contract research and manufacturing services to customers located in 85 countries, today announced financial results for the third quarter of fiscal year (FY) 2012, ended December...

BETHESDA, Md., Feb. 10, 2012 /- Spherix Incorporated (NASDAQ: SPEX) -- an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis, and provider of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical companies -- today announced that Dr. Claire Kruger, Chief Executive Officer, will present to...

ANAHEIM, Calif., Feb. 10, 2012  /- Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR ) announced today that executive management will present at the Leerink Swann Global Healthcare Conference to be held on February 15-16, 2012 in New York.  Steve Cartt, Executive Vice President and Chief Business Officer, is scheduled to present an overview of the Company on Thursday, Februar...

LONDON, February 10, 2012 /- -- Tony Sedgwick steps up to Chief Executive Officer from Chief Business Officer -- -- Thomas Christély resigns as a Director of the Company -- Silence Therapeutics plc (AIM: SLN) ("Silence" or "the Company"), a leading RNA interference (RNAi) therapeutics company, announces today the promotion of Tony Sedgwick PhD, FRCPath to...

SAN DIEGO, Feb. 9, 2012 /- Orexigen ® Therapeutics, Inc. (Nasdaq: OREX ) today announced that management will be presenting at two upcoming investor conferences.  The details are as follows: The 14th Annual BIO CEO & Investor Conference Date: February 13, 2012 Time:  1:30pm Eastern Time Location:  Waldorf Astoria, New York Speaker:  Michael Narach...

SAN DIEGO, Feb. 9, 2012 /- Ambit Biosciences today announced that Michael A. Martino, Ambit's president and chief executive officer, will provide an overview of the company and an update about its clinical development programs, including quizartinib, at two upcoming investor conferences at the Waldorf Astoria in New York City. 14th Annual BIO CEO & Investor Conference...

STEVENAGE, England, February 9, 2012 /- First tenant moves in Stevenage Bioscience Catalyst (SBC), the UK's first open innovation bioscience campus, is pleased to announce that it is now open for business. In addition, it has welcomed its first tenant, Aptiv Solutions , which has taken space in the Incubator building. SBC expects its first year of operation to be a busy one - d...

ORLANDO, Fla., Feb. 9, 2012 /- Micross Components, a leading global provider of distributed and specialty electronic solutions, is pleased to announce its participation in the "Drive for Innovation" tour, sponsored by Avnet Express and UBM Electronics. Included as a "pit stop" during the tour's recent swing through Central Florida, Micross was selected because of its role in po...

BILLERICA, Mass., Feb. 8, 2012 /- BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced today the availability of the new BD Mosaic™ Mesenchymal Stem Cell Serum-Free (hMSC SF), a complete cell culture environment for human mesenchymal stem cells (hMSCs) derived from bone marrow. The BD Mosaic hMSC cell culture environment is designed to provide cell exp...

ROCKVILLE, Md., Feb. 8, 2012 /- Neuralstem, Inc. (NYSE Amex: CUR ) announces that President and CEO Richard Garr will present at the 14th Annual BIO CEO & Investor Conference 2012 in New York City on Monday, February 13, at 3:00 p.m. EST. Garr will present a business overview, and an update on the company's ongoing clinical trials in both its cell therapy and pharmaceutic...

IPSWICH, Mass. and LA JOLLA, Calif., Feb. 7, 2012 /- New England Biolabs, Inc. (NEB) and Synthetic Genomics, Inc. (SGI) jointly announce that they have entered into a licensing agreement whereby NEB will introduce a master mix based on Gibson Assembly™, a revolutionary technology developed by Dr. Daniel Gibson and his colleagues at the J. Craig Venter Institute (JCVI...

One area of intensive research at the nanoscale is the creation of electrically conductive meshes made of metal nanowires. Promising exceptional electrical throughput, low cost and easy processing, engineers foresee a day when such meshes are common in new generations of touch-screens, video displays, light-emitting diodes and thin-film solar cells. Standing in the way, however, is a m...

Tiny metallic nanoparticles that shimmer in the light like the scales on a butterfly's wing are set to become the color-change components of a revolutionary new approach to point-of-care medical diagnostics, according to a study published in International Journal of Design Engineering . Thomas Schalkhammer and colleagues at Attophotonics Biosciences GmbH in Austria are working with Roland...

REDWOOD CITY, Calif., Feb. 6, 2012 /- Genomic Health, Inc. (Nasdaq: GHDX ) today reported financial results and business progress for the year ended December 31, 2011.   Total revenue for the year ended December 31, 2011 increased to $206.1 million, compared with $178.1 million in 2010, an increase of 16 percent.  Product revenue was $204.8 million, compared with $174....

SAN DIEGO, Feb. 6, 2012 /- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) announced today that Kevin Gorman, President and Chief Executive Officer of Neurocrine Biosciences, will be presenting at the 14th Annual BIO CEO & Investor Conference in New York.    The live presentation takes place on Monday, February 13 at 11:30 a.m. Eastern Time / 8:30 a.m. Pacific Time.&#...

AUSTIN, Texas, Feb. 6, 2012 /PRNewswire-USNewswire/ -- Dietary supplements are subject to a wide array of federal government regulations in the United States, according to a new report published by the nonprofit American Botanical Council (ABC). The article notes numerous authorities to regulate dietary supplements that are granted to the U.S. Food and Drug Administration (FDA) and the Federal...

HUNTSVILLE, Ala., Feb. 6, 2012 /- The Angel Investor Management (AIM) Group announced today the formation of the Central Alabama Angel Network (CANN) to serve the capital needs of entrepreneurs and investors in a seven-county region. "The Angel Investor Management Group is bringing together a single network of angel investor groups in Alabama. By banding together to share th...

INDIANAPOLIS, Feb. 6, 2012 /- BioStorage Technologies, a global provider of comprehensive sample management solutions, biomaterial storage and cold chain logistics for the bioscience industry, will host its Global Sample Management Benchmarking Workshop at Partnerships in Clinical Trials on Tuesday, March 6, 2012 at the Marriott World Center in Orlando, Florida.  The 2-...

WASHINGTON and NEW YORK, Feb. 6, 2012 /- Accelerate Brain Cancer Cure (ABC2) and Exosome Diagnostics are collaborating with leading academic medical centers to accelerate clinical validation of Exosome's blood and cerebrospinal fluid-based molecular diagnostics technology in brain cancer.  The collaboration will explore the capabilities of Exosome RNA biofluid-based...

RESEARCH TRIANGLE PARK, N.C., Feb. 6, 2012 /- Chimerix, Inc., a biotechnology company developing novel antiviral therapeutics, today announced positive results from CMX001 Study 201, a Phase 2 study evaluating CMX001 for the prevention of cytomegalovirus (CMV) disease in hematopoietic stem cell transplant (HCT) recipients. CMX001 is a broad spectrum Lipid-Antiviral-Conjugate co...